[1] Lee SH, Coger RN, Clemens MG. Antioxidant functionality in hepatocytes using the enhanced collagen extracellular matrix under different oxygen tensions[J]. Tissue Eng, 2006, 12(10):2825-2834.
[2] Muschler GF, Nakamoto C, Griffith LG. Engineering principles of clinical cell-based tissue engineering[J]. J Bone Joint Surg Am, 2004, 86-A(7):1541-1558.
[3] Yu H, VandeVord PJ, Mao L, et al. Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization[J]. Biomaterials, 2009, 30(4):508-517.
[4] Magri D, Fancher TT, Fitzgerald TN, et al. Endothelial progenitor cells: a primer for vascular surgeons [J]. Vascular, 2007, 15(6):384-394.
[5] Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis[J]. Science, 1997, 275(5302):964-967.
[6] Szmitko PE, Fedak PW, Weisel RD, et al. Endothelial progenitor cells: new hope for a broken heart[J]. Circulation, 2003, 107(24):3093-3100.
[7] Asahara T, Masuda H, Takahashi T,et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization[J]. Circ Res, 1999, 85(3):221-228.
[8] Veleva AN, Heath DE, Cooper SL, et al. Selective endothelial cell attachment to peptide-modified terpolymers[J]. Biomaterials, 2008, 29(27):3656-3661.
[9] Fuchs S, Hermanns MI, Kirkpatrick CJ. Retention of a differentiated endothelial phenotype by outgrowth endothelial cells isolated from human peripheral blood and expanded in long-term cultures[J]. Cell Tissue Res, 2006, 326(1):79-92.
[10] Murasawa S, Asahara T. Endothelial progenitor cells for vasculogenesis[J]. Physiology (Bethesda), 2005, 20:36-42.
[11] Santos MI, Reis RL. Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges[J]. Macromol Biosci, 2010, 10(1):12-27.
[12] Leone AM, Valgimigli M, Giannico MB, et al. From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells[J]. Eur Heart J, 2009, 30(8):890-899.
[13] Hoenig MR, Bianchi C, Sellke FW. Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis[J]. Curr Drug Targets, 2008, 9(5):422-435.
[14] Tura O, Crawford J, Barclay GR. Granulocyte colony-stimulating factor (G-CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy[J]. J Thromb Haemost, 2010, 8(7):1614-1623.
[15] Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization[J]. J Clin Invest, 1999, 103(9):1231-1236.
[16] Murayama T, Tepper OM, Silver M,et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo[J]. Exp Hematol, 2002, 30(8):967-972.
[17] Kinnaird T, Stabile E, Burnett MS, et al.Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences[J]. Circ Res, 2004, 95(4):354-363.
[18] Rehman J, Li J, Orschell CM, et al. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors[J]. Circulation, 2003, 107(8):1164-1169.
[19] Kawamoto A, Tkebuchava T, Yamaguchi J, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia[J]. Circulation, 2003, 107(3):461-468.
[20] Fan Y, Shen F, Frenzel T,et al. Endothelial progenitor cell transplantation improves long-term stroke outcome in mice[J]. Ann Neurol, 2010, 67(4):488-497.
[21] Melero-Martin JM, De Obaldia ME, Kang SY,et al. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells[J]. Circ Res, 2008, 103(2):194-202.
[22] Wu X, Rabkin-Aikawa E, Guleserian KJ, et al. Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells[J]. Am J Physiol Heart Circ Physiol, 2004, 287(2):H480-487.
[23] Stahl A, Wu X, Wenger A, et al. Endothelial progenitor cell sprouting in spheroid cultures is resistant to inhibition by osteoblasts: a model for bone replacement grafts[J].FEBS Lett, 2005, 579(24):5338-5342.
[24] Ankeny RF, Ankeny CJ, Nerem RM, et al. Maturing EPCs into endothelial cells: may the force be with the EPCs: focus on "Find shear stress induces differeedtiation of circulating phenotyoe endothelial proenitor cells" [J]. Am J Physiol Cell Physiol, 2012, 303(6):C589-C591.
[25] 王永刚,裴国献.血管束植入在组织工程骨血管化构建中的作用[J]. 解放军医学杂志, 2007, 32(1):26 -28.
[26] Lokmic Z, Stillaert F, Morrison WA, et al. An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct[J]. FASEB J, 2007, 21(2):511-522.
[27] 张兴文,王佐林. 组织工程骨与Bio-oss修复大鼠下颌骨缺损的比较研究[J]. 口腔颌面外科杂志, 2009, 19(5):329-333.
[28] Yu H, VandeVord PJ, Mao L, et al. Improved tissue engineered bone regeneration by endothelial cell mediated vascularization[J]. Biomaterials, 2009, 30(4):508-517.
[29] Kim S, von Recum H. Endothelial stem cells and precursors for tissue engineering: cell source, differentiation, selection, and application[J]. Tissue Eng Part B Rev, 2008, 14(1):133-147.
[30] Nomi M, Atala A, Coppi PD,et al. Principals of neovascularization for tissue engineering[J]. Mol Aspects Med, 2002, 23(6):463-483.
[31] Chi JT, Chang HY, Haraldsen G, et al. Endothelial cell diversity revealed by global expression profiling[J]. Proc Natl Acad Sci U S A, 2003, 100(19):10623-10628.
[32] Marsboom G, Janssens S. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies[J]. Expert Rev Cardiovasc Ther, 2008, 6(5):687-701.
[33] Kaushal S, Amiel GE, Guleserian KJ, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo[J]. Nat Med, 2001, 7(9):1035-1040.
[34] Matsumoto T, Kawamoto A, Kuroda R,et al. Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing[J]. Am J Pathol, 2006, 169(4):1440-1457.
[35] Matsumoto T, Kuroda R, Mifune Y, et al. Circulating endothelial/skeletal progenitor cells for bone regeneration and healing[J]. Bone, 2008, 43(3):434-439.
[36] Gieseke F, Bohringer J, Bussolari R, et al. Human multi-potent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells[J]. Blood, 2010, 116(19): 3770- 3779.
[37] Han KH, Kang HG, Gil HJ, et al. The immunesuppressive effect of embryonic stem cells and mesenchymal stem cells on both primary and secondary alloimmune res ponses[J] . Transpl Immunol, 2010, 23(3):141-146.
[38] Fuchs S, Ghanaati S, Orth C,et al. Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds[J]. Biomaterials, 2009, 30(4):526-534.
[39] Unger RE, Sartoris A, Peters K, et al.Tissue-like self-assembly in cocultures of endothelial cells and osteoblasts and the formation of microcapillary-like structures on three-dimensional porous biomaterials[J]. Biomaterials, 2007, 28(27):3965-3976.
[40] Tarkka T, Sipola A, Jamsa T, et al. Adenoviral VEGF-A gene transfer induces angio- genesis and promotes bone formation in healing osseous tissues[J]. J Gene Med, 2003, 5(7):560-566.
[41] Bouletreau PJ, Warren SM, Spector JA, et al. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing[J]. Plast Reconstr Surg, 2002, 109(7):2384-2397.
[42] Usami K, Mizuno H, Okada K,et al. Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation[J]. J Biomed Mater Res A, 2009, 90(3):730-741.
[43] Yu H, Vandevord PJ, Gong W, et al. Promotion of osteogenesis in tissue-engineered bone by pre-seeding endothelial progenitor cells-derived endothelial cells[J]. J Orthop Res, 2008, 26(8):1147-1152.
[44] Aguirre A, Planeu JA, Engel E. Dynamics of bone marrow-derived endothelial progenitor cell/mesenchymal stem cell interaction in co-culture and its implications in angiogenesis[J]. Biochem Biophys Res Commun, 2010, 400(2):284-291.
[45] Amini AR, Laurencin CT, Nukavarapu SP. Differential analysis of peripheral blood- and bone marrow-derived endothelial progenitor cells for enhanced vascularization in bone tissue engineering[J]. J Orthop Res, 2012, 30(9):1507-1515. |